Literature DB >> 16413575

Suppression of dynamic Ca(2+) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition.

Yuejin Wu1, Ayumi Shintani, Chad Grueter, Rong Zhang, Yue Hou, Jinying Yang, Evangelia G Kranias, Roger J Colbran, Mark E Anderson.   

Abstract

The multifunctional Ca(2+) and calmodulin-dependent protein kinase II (CaMKII) is important for regulating L-type Ca(2+) current (I(Ca)) and cytoplasmic Ca(2+) (Ca(2+)(i)) uptake and release from the sarcoplasmic reticulum (SR), key elements of the 'Ca(2+)-induced Ca(2+) release' (CICR) mechanism. However, the effects of chronic CaMKII inhibition on Ca(2+)(i) responses during CICR are unknown. We hypothesized that chronic CaMKII inhibition significantly affects CICR in ventricular myocytes. We studied CICR by simultaneously measuring Ca(2+)(i) transients and I(Ca) in voltage-clamped ventricular myocytes isolated from a recently developed genetic mouse model of cardiac CaMKII inhibition. These measurements were repeated in ventricular myocytes from novel mice with cardiac CaMKII inhibition lacking phospholamban (PLN), a known CaMKII substrate and a negative regulator of Ca(2+)(i) uptake into the SR Ca(2+) store. CaMKII inhibition eliminated a pattern of I(Ca) increases called facilitation and significantly reduced beat-to-beat and cell-to-cell variability of peak Ca(2+)(i) transients in ventricular myocytes with PLN. PLN ablation eliminated I(Ca) facilitation even in the absence of CaMKII inhibition and the effects of CaMKII inhibition to reduce SR Ca(2+) content and slow SR Ca(2+) uptake were lost in the absence of PLN. PLN ablation significantly reduced I(Ca) beat-to-beat variability in cells with CaMKII inhibition. These findings show that chronic CaMKII inhibition reduces variability of CICR responses in a manner that is partly dependent on the presence of PLN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413575     DOI: 10.1016/j.yjmcc.2005.11.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.

Authors:  Chad E Grueter; Roger J Colbran; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

2.  A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice.

Authors:  Thomas J Hund; Olha M Koval; Jingdong Li; Patrick J Wright; Lan Qian; Jedidiah S Snyder; Hjalti Gudmundsson; Crystal F Kline; Nathan P Davidson; Natalia Cardona; Matthew N Rasband; Mark E Anderson; Peter J Mohler
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

Review 3.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

Review 4.  Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation.

Authors:  Dobromir Dobrev; Xander H T Wehrens
Journal:  Trends Cardiovasc Med       Date:  2010-01       Impact factor: 6.677

Review 5.  CaMKII in the cardiovascular system: sensing redox states.

Authors:  Jeffrey R Erickson; B Julie He; Isabella M Grumbach; Mark E Anderson
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

6.  PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban.

Authors:  Liang Xie; Xinchun Pi; W H Davin Townley-Tilson; Na Li; Xander H T Wehrens; Mark L Entman; George E Taffet; Ashutosh Mishra; Junmin Peng; Jonathan C Schisler; Gerhard Meissner; Cam Patterson
Journal:  J Clin Invest       Date:  2015-06-15       Impact factor: 14.808

7.  A Single Protein Kinase A or Calmodulin Kinase II Site Does Not Control the Cardiac Pacemaker Ca2+ Clock.

Authors:  Yuejin Wu; Héctor H Valdivia; Xander H T Wehrens; Mark E Anderson
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-02

8.  Regulation of cardiac ATP-sensitive potassium channel surface expression by calcium/calmodulin-dependent protein kinase II.

Authors:  Ana Sierra; Zhiyong Zhu; Nicolas Sapay; Vikas Sharotri; Crystal F Kline; Elizabeth D Luczak; Ekaterina Subbotina; Asipu Sivaprasadarao; Peter M Snyder; Peter J Mohler; Mark E Anderson; Michel Vivaudou; Leonid V Zingman; Denice M Hodgson-Zingman
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

Review 9.  Beta-adrenergic receptor signaling in the heart: role of CaMKII.

Authors:  Michael Grimm; Joan Heller Brown
Journal:  J Mol Cell Cardiol       Date:  2009-10-31       Impact factor: 5.000

10.  Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.

Authors:  Haiyun Ling; Tong Zhang; Laetitia Pereira; Christopher Kable Means; Hongqiang Cheng; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Ju Chen; Donald Bers; Joan Heller Brown; Joan Heller Brown
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.